atrial fibrillation/умор

Веза се чува у привремену меморију

Изаберите тип сортирања

Страна 1 од 131 резултати

Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes?

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Background : Exercise-induced arterial hypertension (EIAH) leads to myocardial hypertrophy and is associated with a poor prognosis. EIAH might be related to the "cardiac fatigue" caused by endurance training. The goal of this study was to examine whether there is any relationship between EIAH and

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Although first described about 100yr ago, atrial fibrillation (AF) is now recognized as the most common of all arrhythmias. It has a substantial morbidity and presents a considerable health care burden. Improved diagnosis and an ageing population with an increased likelihood of underlying cardiac

Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Few studies describe oral anticoagulant (OAC) prescription practices in very elderly patients with atrial fibrillation (AF). METHODS In this sub-analysis of the PREFER in AF study, performed in 2012, patients were stratified according to age (<80 [n=5565] and ≥80years [n=1660]) and OAC

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Little is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. RESULTS In the Prevention of Thromboembolic Events-European Registry in Atrial Fibrillation (n=6196 patients with atrial fibrillation; mean±SD age, 71.8±10.4 years; 39.7% women),

Atrial fibrillation due to late amiodarone-induced thyrotoxicosis.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

A 60-year-old male patient complaining of palpitations, fatigue, weakness and weight loss of 1 month's duration was hospitalized in our cardiology department for atrial fibrillation. Thyroid function test results were compatible with thyrotoxicosis. The patient had been taking amiodarone for 2.5

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND In contrast to surveys in cardiologist settings, presentation and management of atrial fibrillation (AF) in primary care patients is less well studied. RESULTS The prospective ATRIUM (Outpatient Registry Upon Morbidity of Atrial Fibrillation) collected data from patients with AF seen by

Cost effectiveness of therapies for atrial fibrillation. A review.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Atrial fibrillation is the most common supraventricular tachyarrhythmia encountered in clinical practice, affecting over 5% of persons over the age of 65 years. A common pathophysiological mechanism for arrhythmia development is atrial distention and fibrosis induced by hypertension, coronary artery

Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND The purpose of the study was to evaluate the effect of AV junction ablation and pacemaker implantation on quality of life and specific symptoms in patients with paroxysmal atrial fibrillation (AF) not controlled by drugs. RESULTS We performed a multicenter, randomized, 6-month evaluation

Clinical characteristics of persistent lone atrial fibrillation in the RACE study.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

In the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study, 522 patients were randomized to either rate or rhythm control therapy. Lone atrial fibrillation (AF) was present in 89 patients. Demographics, cardiovascular mortality and morbidity, and quality of

Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Azimilide is a new antiarrhythmic agent being developed for the management for atrial fibrillation and flutter (AF). Four randomized, placebo-controlled, double-blind trials have been performed that investigated the effect of azimilide on time to first recurrence of symptomatic AF. This

Atrial fibrillation: choosing an antiarrhythmic drug.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Atrial fibrillation is the most common arrhythmia encountered in clinical practice. The associated hemodynamic changes can lead to symptoms of palpitations, fatigue, light-headedness, or dyspnea. Extensive research in the use of antiarrhythmic drugs has been performed both to facilitate the

Pulse check as a tool to raise awareness of atrial fibrillation in pharmacies in the Czech Republic - a pilot project.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The aim of the study was to raise the awareness of atrial fibrillation (AF) and the importance of pulse check in Czech pharmacies as well as to point out further possibilities of developing consulting activities in pharmacies.Our project was performed as

Incidence of atrial fibrillation in an Italian population followed by their GPs through a telecardiology service.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Atrial fibrillation (AF) is the most common sustained cardiac tachyarrhythmia and is often an occasional diagnosis in the absence of known cardiac disease. The aim of this study is to describe an Italian patient population with AF followed by their General Practitioners (GPs) using a

Ablation for atrial fibrillation: an evidence-based analysis.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To review the effectiveness, safety, and costing of ablation methods to manage atrial fibrillation (AF). The ablation methods reviewed were catheter ablation and surgical ablation. OBJECTIVE Atrial fibrillation is characterized by an irregular, usually rapid, heart rate that limits the

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting millions of individuals worldwide. The rapid, irregular, and disordered electrical activity in the atria gives rise to palpitations, fatigue, dyspnea, chest pain and dizziness with or without syncope. Patients with

Претходна
1
2
3
4
5
6
...
8
9
Следећи

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима